Publicaciones en colaboración con investigadores/as de University of Duisburg-Essen (33)

2023

  1. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Leukemia, (2022), 36, 7, (1720-1748), 10.1038/s41375-022-01620-2)

    Leukemia

  2. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    European Urology

  3. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    European Journal of Cancer

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight

    eLife, Vol. 10

2020

  1. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations

    Journal of Allergy and Clinical Immunology, Vol. 146, Núm. 4, pp. 901-911

2018

  1. Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8 + T Cell Cross-Priming

    Cell Reports, Vol. 22, Núm. 6, pp. 1484-1495

2017

  1. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Journal of the American College of Cardiology, Vol. 69, Núm. 7, pp. 777-785

2016

  1. An update on atrial fibrillation in 2014: From pathophysiology to treatment

    International Journal of Cardiology, Vol. 203, pp. 22-29

  2. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687

  3. Validated risk score for predicting 6-month mortality in infective endocarditis

    Journal of the American Heart Association, Vol. 5, Núm. 4

2015

  1. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases

    Russian Journal of Cardiology, Vol. 123, Núm. 7, pp. 7-72

  2. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis a prospective study from the international collaboration on endocarditis

    Circulation, Vol. 131, Núm. 2, pp. 131-140

  3. Candida infective endocarditis: An observational cohort study with a focus on therapy

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 4, pp. 2365-2373

  4. Impact of early valve surgery on outcome of staphylococcus aureus prosthetic valve infective endocarditis: Analysis in the international collaboration of endocarditis-prospective cohort study

    Clinical Infectious Diseases, Vol. 60, Núm. 5, pp. 741-749

  5. One-year outcome following biological or mechanical valve replacement for infective endocarditis

    International Journal of Cardiology, Vol. 178, pp. 117-123

2014

  1. 2014 ESC guidelines on the diagnosis and treatment of aortic diseases

    European Heart Journal, Vol. 35, Núm. 41, pp. 2873-2926

  2. Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): Insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry

    EuroIntervention, Vol. 10, Núm. 8, pp. 975-981

  3. Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations

    Clinical Cancer Research, Vol. 20, Núm. 16, pp. 4251-4261

2013

  1. HACEK Infective Endocarditis: Characteristics and Outcomes from a Large, Multi-National Cohort

    PLoS ONE, Vol. 8, Núm. 5